Hjem › Neuroblastom › Kentucky
Kliniske studier for Neuroblastom i Kentucky
5 studier for Neuroblastom søker deltakere på steder i Kentucky.
Byer i Kentucky
Offisiell studietekst (engelsk)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- University of Kentucky/Markey Cancer Center, Lexington
- Norton Children's Hospital, Louisville
RekruttererFase 3
Opp til 30 år · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06172296Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine, Louisville
RekruttererFase 2
Opp til 22 år · Alle kjønn · Oppdatert 4. sep. 2026 · NCT02559778Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine, Louisville
RekruttererFase 1/2
Opp til 30 år · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06541262Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- University of Kentucky/Markey Cancer Center, Lexington
RekruttererFase 3
365 Days – 30 Years · Alle kjønn · Oppdatert 25. aug. 2026 · NCT03126916Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine, Louisville
RekruttererFase 2
12 Months – 21 Years · Alle kjønn · Oppdatert 12. aug. 2026 · NCT05489887Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.